JP2020511457A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511457A5
JP2020511457A5 JP2019549506A JP2019549506A JP2020511457A5 JP 2020511457 A5 JP2020511457 A5 JP 2020511457A5 JP 2019549506 A JP2019549506 A JP 2019549506A JP 2019549506 A JP2019549506 A JP 2019549506A JP 2020511457 A5 JP2020511457 A5 JP 2020511457A5
Authority
JP
Japan
Prior art keywords
compound
ethyl
chloro
methoxypiperidin
imidazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019549506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511457A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2018/010670 external-priority patent/WO2018169092A1/en
Publication of JP2020511457A publication Critical patent/JP2020511457A/ja
Publication of JP2020511457A5 publication Critical patent/JP2020511457A5/ja
Pending legal-status Critical Current

Links

JP2019549506A 2017-03-14 2018-03-13 ヒドロキシアルキルチアジアゾール誘導体のn−ホスホノキシメチルプロドラッグ Pending JP2020511457A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201711008754 2017-03-14
IN201711008754 2017-03-14
PCT/JP2018/010670 WO2018169092A1 (en) 2017-03-14 2018-03-13 N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives

Publications (2)

Publication Number Publication Date
JP2020511457A JP2020511457A (ja) 2020-04-16
JP2020511457A5 true JP2020511457A5 (https=) 2020-07-27

Family

ID=62002340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549506A Pending JP2020511457A (ja) 2017-03-14 2018-03-13 ヒドロキシアルキルチアジアゾール誘導体のn−ホスホノキシメチルプロドラッグ

Country Status (6)

Country Link
US (1) US10752647B2 (https=)
EP (1) EP3596071A1 (https=)
JP (1) JP2020511457A (https=)
CA (1) CA3056571C (https=)
TW (1) TW201840322A (https=)
WO (1) WO2018169092A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
WO2006087544A2 (en) 2005-02-18 2006-08-24 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
NZ561613A (en) 2005-02-18 2010-12-24 Astrazeneca Ab Antibacterial piperidine derivatives
CN101163674A (zh) 2005-02-18 2008-04-16 阿斯利康(瑞典)有限公司 作为dna促旋酶和拓扑异构酶抑制剂的吡咯衍生物
US20080269214A1 (en) 2005-03-04 2008-10-30 Astrazeneca Ab Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
CN101171250A (zh) 2005-03-04 2008-04-30 阿斯利康(瑞典)有限公司 具有抗菌活性的氮杂环丁烷和吡咯的三环衍生物
JP2009520785A (ja) 2005-12-23 2009-05-28 アストラゼネカ アクチボラグ 抗菌性のピロロピリジン、ピロロピリミジン、及びピロロアゼピン
WO2008020229A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
WO2008020227A2 (en) 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200819437A (en) 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
TW200906412A (en) 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
TWI498115B (zh) 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
US20120108565A1 (en) 2008-07-30 2012-05-03 Lalima Sharma Pyrrole carboxylic acid derivatives as antibacterial agents
TW201026694A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
TW201026695A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596
JP2011026305A (ja) * 2009-06-24 2011-02-10 Daiichi Sankyo Co Ltd イミダゾールカルボニル化合物を含有する医薬組成物
CN103261200B (zh) * 2010-09-13 2016-03-30 阿迪维纳斯疗法有限公司 作为a2b腺苷受体拮抗剂的前药的嘌呤化合物、它们的制备方法及医药用途
WO2014057415A2 (en) 2012-10-10 2014-04-17 Vitas Pharma Research Pvt Ltd Inhibitors of dna gyrase for the treatment of bacterial infections
KR20180054650A (ko) 2015-09-30 2018-05-24 다이이찌 산쿄 가부시키가이샤 히드록시알킬 티아디아졸 유도체

Similar Documents

Publication Publication Date Title
ES2244666T3 (es) Derivados de acidos 3-(heteroaril-acetamido)-2-oxoazetidina-1-sulfonicos utilizados como agentes antibacterianos.
JP6130600B2 (ja) トリサイクリックベンズオキサボロール化合物、その製造方法および用途
CN101232884B (zh) 作为抗菌剂的喹啉衍生物
EP0603887B1 (en) Bicyclic amine derivatives
AU2016330271B2 (en) Hydroxyalkyl thiadiazole derivatives
US7759482B2 (en) Aminoglycosides as antibiotics
JPH10287669A (ja) 置換アミノメチルピロリジン誘導体
KR101413094B1 (ko) 항박테리아제로서의 퀴놀린 유도체
JP2020511457A5 (https=)
JP2020511457A (ja) ヒドロキシアルキルチアジアゾール誘導体のn−ホスホノキシメチルプロドラッグ
US20170355671A1 (en) Peripherally substituted monocyclic beta-lactams
KR20000048687A (ko) 피리도벤족사진 유도체
HK1252275B (en) Hydroxyalkyl thiadiazole derivatives
WO2005073238A1 (ja) ピリドベンズオキサジン誘導体
WO2025049804A2 (en) Agents for the treatment of non-replicating bacteria
CN105492422A (zh) 新型吡咯衍生物
WO1996024593A1 (en) Heterocyclic spiro derivatives
CN105452219A (zh) 新型吡咯衍生物
HK1122210B (en) Quinoline derivatives as antibacterial agents
BG66536B1 (bg) Хинолинови производни като антибактериални средства